The Canadian Cancer Trials Group

Reminder that this Friday (Nov 14th) we #YGK welcome Dr Désy as our special guest speaker discussing Soul Healing: Practicing Medicine in Rural Northern Communities and Building
Understanding within Care Providers - space is still available - Find out more here: buff.ly/CfRbmSE

#RemembranceDay - Today we remember and pay tribute to the Canadian armed forces members who have died in the line of duty. #CCTG honours everyone who continues to serve and who defend our values and freedoms. #LestWeForget

November is #Neuroendocrine (#NET) Cancer Awareness Month. Today CCTG supports World #NETCancerDay to raise awareness for this often-misdiagnosed cancer. Trials like NE2 (STOPNET) are looking to improve outcomes for these patients #LetsTalkAboutNETs buff.ly/mE3LstH

The Canadian cancer research conference #CCRC2025 is now a wrap and #CCTG had a number of poster presentations and an oral presentation on the Development of Patient Priorities in Cancer Research by Judy Needham! Find out more: buff.ly/PSMnJ4S

#CCTG and #CancerResearchInstitute announce the first patient enrolled in a new sub-study for the #IPROC ovarian cancer #immunotherapy platform trial - a new #immunotherapy combination and patient population, accelerating progress toward more effective ovarian cancer treatments. buff.ly/rQWkoeZ

November is #LungCancerAwareness Month and #CCTG is raising awareness about lung cancer, its risks, and current research. The BR38 trial is looking at targeted radiotherapy during #immunotherapy for metastatic non-small cell #lungcancer buff.ly/zDyZu8M

#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. www.ctg.queensu.ca/bulletin/cct...

A special Seminar with Dr Jean Desy where he discusses working on the North Shore of Quebec, in Cree country and among the Inuit of Nunavik for 47 years. Teaching literature and medicine at the Faculty of Medicine at Laval University for 23 years.
buff.ly/CfRbmSE

Thanks to the #CCTG sites and #breastcancer patients who participated, making Canada one of the top 10 accruing countries globally. Showing that it is possible to have a temporary interruption of endocrine therapy to permit pregnancy. @cancersociety.bsky.social @ccsresearch.bsky.social

Results from the primary analysis of the ctDNA-negative cohort from the international DYNAMIC-III (CO29) colon cancer clinical trial were presented at the #ESMO25 Presidential Symposium and simultaneously published in #NatureMagazine. @agitg @petermaccc @ccsresearch @cancersociety buff.ly/YeYWTde

Dr Glenwood Goss presents the #CCTG #BR31 study final overall survival and minimal residual disease analyses today at #ESMO25. The trial tested whether there is a benefit to receiving adjuvant immunotherapy after tumour resection in early-stage non-small cell lung cancer.

Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...

The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > buff.ly/ybihH1Y

#BreastCancerAwarenessMonth the #CCTG MAC30 trial is testing the addition of chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning #PinkRibbon, #BCAM buff.ly/ABW5gHI

The Q3 2025 listing of #CCTG trials in development is now live. Find out what trials will be made available soon and which trials have been recently activated > buff.ly/MZzXJI1 buff.ly/MZzXJI1

The Canadian Cancer Trials Group #CCTG is currently seeking applications for a Patient Representative to support the #Gastrointestinal Disease Site Committee. Find out more > buff.ly/kgWqbn7

October is #LiverCancerAwarenessMonth and the #CCTG HE2 trial researchers want to know if the combination of three common drugs used to treat #livercancer can offer better results than the standard treatment. buff.ly/Laeecvk

Queen's University Human Resources and Equity Careers | Human Resources and Staffing Operations Leader | Kingston, , Canada Reporting to the Chief Operating Officer (COO), with accountability to the CCTG Director for Faculty staffing, the Human Resources and Staffing Operations Leader will lead the Human Resources and…

Come join the #CCTG team - apply today for the position of Human Resources and Staffing Operations Leader, responsible for a range of Human Resources and Staffing activities in support of the administration and operation of the group.
buff.ly/iSuoC3n

October is #BreastCancerAwarenessMonth and the #CCTG MAC27 trial is investigating if the combination of a new drug and a commonly used drug is better at preventing HER2-positive #breastcancer from returning #BreastCancerCanada, #BCAM, #PinkForBreastCancer buff.ly/X6OHJjN

National Day for Truth and Reconciliation: CCTG acknowledges the intergenerational impacts of residential schools & colonization. We are committed to reconciliation - designing and conducting trials that are equitable, culturally safe, & accessible for all First Nations, Inuit, & Métis peoples.

#CCTG trial spotlight for #LeukemiaAwarenessMonth & #ChildhoodCancerAwarenessMonth: The ALC6 study is testing if adding another drug to standard treatment improves outcomes for young adults with newly diagnosed B-cell acute lymphoblastic leukemia.
#myeloMATCH

Trial Info -> buff.ly/TZ0YRC0

#CCTG Trial Highlight for #BloodCancerAwarenessMonth: The MY13 study is evaluating whether stopping injections after 18 months can maintain disease control and improve quality of life in older adults with multiple #myeloma.
#MultipleMyeloma #CancerResearch #CCTG

Trial Info -> buff.ly/X6EoYBI

Recognizing #GynecologicCancerAwarenessMonth CCTG VU2 trial - a study is to evaluate if specific testing of vulva cancer tissue removed by surgery provides useful information to decide if additional surgery is needed.
#GCAM #MoveTheMessage

Trial Info -> buff.ly/qmXEtyl

#CCTG trial spotlight for #GynecologicCancerAwarenessMonth: EN10 is exploring if some people with low-risk endometrial cancer can safely receive less treatment after surgery, reducing side effects without affecting outcomes.
#EndometrialCancer #SolvingCancerTogether

Trial Info -> buff.ly/HNFFDOt

September is #ChildhoodCancerAwarenessMonth. #CCTG is committed to advancing research and clinical trials that develop better outcomes for children and their families.
#CancerResearch #SolvingCancerTogether #ChildhoodCancer

Today is #WorldCancerResearchDay—a reminder that research saves lives. #CCTG is committed to developing and conducting cancer clinical trials that lead to better outcomes for cancer patients globally.
#CancerResearch #SolvingCancerTogether #Research

September is #GynecologicCancerAwarenessMonth. #CCTG is dedicated to clinical research that improves treatment options and outcomes for people facing #gynecologic cancers.
#GynecologicCancerAwareness #SolvingCancerTogether

As little as 22 minutes of exercise a day could make a difference in colon cancer patients' survival, landmark study concludes Newly published results of a 17-year-long study conclude that exercise improves outcomes for patients with moderate to severe colon cancer.

A 17-year global study led by the Canadian Cancer Trials Group(CCTG) shows that just 2.5 hrs/week of moderate exercise can reduce colon cancer recurrence by 28% and death by 37%.

Read more on this research 👉 bit.ly/45fIFes

#UNBResearch #ProudlyUNB

Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the #radiotherapy delineation benchmark case procedure, published in the Green Journal.
👉 Read it before your patients: bit.ly/4fLoatJ

Strong showing from #GUonc #patientadvocates @swog.org: Darrell Nakagawa at #S2427 BRIGHT & Joël Pointon at #CCTG-PR.26 kickoff mtgs. Exciting to see new #bladdercancer & #prostatecancer trials open! THANK YOU to SWOG GU Cmte & @supportingswog.bsky.social for including & elevating patient voices!